Max Healthcare Surges on Growth Outlook

  Published 1 year ago

Max Healthcare shares rise 2.4% as Jefferies boosts target to 1,400 rupees, citing 75% capacity expansion and 20% EBITDA growth.

  • Jefferies maintains a "buy" rating with a 1,400-rupee PT, 15% above the current price.
  • MAXE to expand beds to 9,000 in 3-4 years, driven by new units.
  • Stock up 7% YTD, outperforming peers Fortis (6%) and Apollo (down 4%).

You might like these

DLF Q1 Profit Up 18%, Sales Surge

Navkar Q2 FY26 Revenue & EBITDA Growth

Stock Market Highlights: Aug 7, 2025

India's Net Non-Resident Claims Drop to $330 Billion in Q4 2024-25

India Aims $5 Trillion Economy by 2027 Amid Reforms

Coforge Surges on JPM Outlook, Eyes 16% Upside

Aurigene's 2025 Financial Highlights: Profit, Cash Flow, EPS

News that matters the most ⚡